Literature DB >> 19752086

Regulatory myeloid suppressor cells in health and disease.

Srinivas Nagaraj1, Michele Collazo, Cesar A Corzo, Je-In Youn, Myrna Ortiz, David Quiceno, Dmitry I Gabrilovich.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19752086      PMCID： PMC2756310          DOI： 10.1158/0008-5472.CAN-09-2152

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Cancer: inflammation by remote control.

Authors:  Alberto Mantovani
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

2.  Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.

Authors:  Nadja Leukert; Thomas Vogl; Kerstin Strupat; Rudolf Reichelt; Clemens Sorg; Johannes Roth
Journal:  J Mol Biol       Date:  2006-04-21       Impact factor: 5.469

3.  Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.

Authors:  Georg Varga; Jan Ehrchen; Athanasios Tsianakas; Klaus Tenbrock; Anke Rattenholl; Stephan Seeliger; Matthias Mack; Johannes Roth; Cord Sunderkoetter
Journal:  J Leukoc Biol       Date:  2008-07-08       Impact factor: 4.962

4.  SHIP limits immunoregulatory capacity in the T-cell compartment.

Authors:  Michelle M Collazo; Daniela Wood; Kim H T Paraiso; Erin Lund; Robert W Engelman; Cam-Tien Le; Diana Stauch; Katja Kotsch; William G Kerr
Journal:  Blood       Date:  2009-01-09       Impact factor: 22.113

Review 5.  Myeloid-derived suppressor cells: linking inflammation and cancer.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

6.  Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.

Authors:  Moses K Donkor; Elaine Lahue; Traci A Hoke; Laura R Shafer; Ugur Coskun; Joyce C Solheim; Dumrul Gulen; John Bishay; James E Talmadge
Journal:  Int Immunopharmacol       Date:  2009-04-09       Impact factor: 4.932

7.  Notch and wingless signaling cooperate in regulation of dendritic cell differentiation.

Authors:  Jie Zhou; Pingyan Cheng; Je-In Youn; Matthew J Cotter; Dmitry I Gabrilovich
Journal:  Immunity       Date:  2009-06-11       Impact factor: 31.745

8.  Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.

Authors:  Cecilia Melani; Sabina Sangaletti; Francesca M Barazzetta; Zena Werb; Mario P Colombo
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

9.  Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

Authors:  Paolo Serafini; Kristen Meckel; Michael Kelso; Kimberly Noonan; Joseph Califano; Wayne Koch; Luigi Dolcetti; Vincenzo Bronte; Ivan Borrello
Journal:  J Exp Med       Date:  2006-11-13       Impact factor: 14.307

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307
  10 in total
  38 in total

Review 1.  Myeloid suppressor cells and immune modulation in lung cancer.

Authors:  Minu K Srivastava; Åsa Andersson; Li Zhu; Marni Harris-White; Jay M Lee; Steven Dubinett; Sherven Sharma
Journal:  Immunotherapy       Date:  2012-03       Impact factor: 4.196

2.  Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.

Authors:  Rajakumar Mandraju; Sean Murray; James Forman; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

3.  Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.

Authors:  Tillmann Michels; Galina V Shurin; Hiam Naiditch; Alexandra Sevko; Viktor Umansky; Michael R Shurin
Journal:  J Immunotoxicol       Date:  2012-01-28       Impact factor: 3.000

Review 4.  Genetically engineered mucin mouse models for inflammation and cancer.

Authors:  Suhasini Joshi; Sushil Kumar; Sangeeta Bafna; Satyanarayana Rachagani; Kay-Uwe Wagner; Maneesh Jain; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

5.  Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection.

Authors:  Lucio Gama; Erin N Shirk; Julia N Russell; Karina I Carvalho; Ming Li; Suzanne E Queen; Jorge Kalil; M Christine Zink; Janice E Clements; Esper G Kallas
Journal:  J Leukoc Biol       Date:  2012-02-24       Impact factor: 4.962

6.  Role of myeloid-derived suppressor cells in autoimmune disease.

Authors:  Kristen R Crook; Peng Liu
Journal:  World J Immunol       Date:  2014-03-27

7.  Pak2 regulates myeloid-derived suppressor cell development in mice.

Authors:  Yi Zeng; Seongmin Hahn; Jessica Stokes; Emely A Hoffman; Monika Schmelz; Maria Proytcheva; Jonathan Chernoff; Emmanuel Katsanis
Journal:  Blood Adv       Date:  2017-10-10

8.  Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection.

Authors:  Fanhang Meng; SiYang Chen; Xuekun Guo; Zhiyong Chen; Xianen Huang; Yongtong Lai; Minzhuan Lin
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  TGF-β and VEGF cooperatively control the immunotolerant tumor environment and the efficacy of cancer immunotherapies.

Authors:  Tristan Courau; Djamel Nehar-Belaid; Laura Florez; Béatrice Levacher; Thomas Vazquez; Faustine Brimaud; Bertrand Bellier; David Klatzmann
Journal:  JCI Insight       Date:  2016-06-16

Review 10.  Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Authors:  Mohamed Labib Salem; David J Cole
Journal:  Cancer Immunol Immunother       Date:  2009-11-18       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.